Knud Kragballe
- Dermatology top 0.05%
- Dermatology and Skin Diseases 79
- Immunology top 0.2%
- Psoriasis: Treatment and Pathogenesis 120
- Immune Response and Inflammation 17
- Immunology and Allergy top 1%
- Pathology and Forensic Medicine top 0.5%
- Vitamin D Research Studies 25
- Autoimmune Bullous Skin Diseases 13
- Rheumatology top 1%
-
- Asthma and respiratory diseases 31
-
- Retinoids in leukemia and cellular processes 20
-
- NF-κB Signaling Pathways 17
Knud Kragballe
253 papers receiving 8.8k citations
Peers
Comparison fields: 5 of 135
- Dermatology 3.6k
- Immunology 5.2k
- Immunology and Allergy 592
- Pathology and Forensic Medicine 1.4k
- Rheumatology 866
Countries citing papers authored by Knud Kragballe
This map shows the geographic impact of Knud Kragballe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knud Kragballe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knud Kragballe more than expected).
Fields of papers citing papers by Knud Kragballe
This network shows the impact of papers produced by Knud Kragballe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knud Kragballe. The network helps show where Knud Kragballe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Knud Kragballe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 110 | |
| 2 | 2012 | 15 | |
| 3 | 2010 | 20 | |
| 4 | 2010 | 82 | |
| 5 | 2009 | 84 | |
| 6 | 2007 | 85 | |
| 7 | 2007 | 34 | |
| 8 | 2006 | 121 | |
| 9 | 2006 | 31 | |
| 10 | 1997 | 22 | |
| 11 | 1996 | 9 | |
| 12 | 1994 | 1 | |
| 13 | 1992 | 54 | |
| 14 | 1991 | 60 | |
| 15 | [Polyunsaturated fatty acid preparations available on the Danish market. Composition and oxidative stability]. | 1990 | 2 |
| 16 | A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5. | 1989 | 42 |
| 17 | 1987 | 15 | |
| 18 | 1981 | 7 | |
| 19 | 1980 | 12 | |
| 20 | 1979 | 6 |
About Knud Kragballe
Knud Kragballe is a scholar working on Dermatology, Immunology and Immunology and Allergy, having authored 256 papers that have together received 9.2k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (120 papers), Dermatology and Skin Diseases (79 papers), Asthma and respiratory diseases (31 papers), Vitamin D Research Studies (25 papers), Retinoids in leukemia and cellular processes (20 papers), NF-κB Signaling Pathways (17 papers), Immune Response and Inflammation (17 papers) and Autoimmune Bullous Skin Diseases (13 papers). The work is most often cited by research in Dermatology (3.6k citations), Immunology (5.2k citations) and Immunology and Allergy (592 citations). Knud Kragballe has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Lars Iversen, Claus Johansen, Troels Herlin, K. Fogh, H. Søgaard, H Zachariae, Karsten Fogh, John J. Voorhees, T.N. Dam and Rasmus Boye Kjellerup. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.